(Revised June 1, 2020)
The Code of Federal Regulation
21CFR184.1857 defines dextrose as “corn sugar,” which is produced from the “complete
hydrolysis of corn starch with safe and suitable acids or enzymes, followed by
refinement and crystallization from the resulting hydrolysate.”
It is for this reason that IV fluid with added
dextrose (corn sugar derived from cornstarch) is clearly contraindicated for administration
to corn-allergic patients in the package insert; however, some IV fluids with
added dextrose are lacking this critical contraindication warning.
Diane H., Corn Allergy Advocate
Corn Allergy Advocacy/Resources
Twitter: @CornAllergy911
References:
BCPharmacists, "Warning: corn-related allergens . . ."
"Probable anaphylactic reaction to corn-derived dextrose
solution."
LACTATED RINGER’S IN 5% DEXTROSE CONTRAINDICATED FOR
CORN-ALLERGIC PATIENTS
PETITION: DRUG PRODUCTS W/DEXTROSE MUST BE UNIFORMLY
CONTRAINDICATED FOR CORN-ALLERGIC PATIENTS
Vitamin K1 Injection Contains Corn-Derived Dextrose [NO
CONTRAINDICATION WARNING]
ACD-A Anticoagulant Citrate Dextrose Solution, Solution A [NO
CONTRAINDICATION WARNING]
My March 5, 2020, Email to the FDA Re: Dextrose (Corn Sugar),
Code of Federal Regulation 21CFR184.1857, vs. Glucose (Blood Sugar)
My April 20, 2020, Email to the Children’s Hospital of
Philadelphia Re: Corn Allergies and Vaccine
My May 11, 2020, Email to the FDA Re: Corn-Derived Excipients in
Vaccines
Published Corn Allergy Studies/Statistics (“. . . Maize major allergen . . .”)
No comments:
Post a Comment